腸管グルカゴンに及ぼす下垂体の影響
スポンサーリンク
概要
- 論文の詳細を見る
It has been reported that gut glucagon immunoreactivity (Gut GI) and gut glucagon-like immunoreactivity (Gut GLI) increase markedly day by day in total pancreatectomized dogs without insulin injections. However, the regulation mechanism of the release of Gut GI and Gut GLI has still not been completely resolved. <BR>The present studies were designed to find a part of the regulation mechanism of the release of Gut GI and Gut GLI in connection with hypophysis and also to examine the relation between gut glucagon and blood sugar levels after pancreatectomy. <BR>Eight healthy mongrel dogs, weighing 10-13 Kg, which had fasted for twelve hours, were used. Under Ketalar and also Ravonal anesthesia, total pancreatectomy of these dogs was performed through a midline abdominal incision. Thereafter, these dogs were maintained without insulin therapy for three days. On the fourth day, under Ketalar anesthesia, the hypophysis of these dogs was removed under the direct vision through the temporal approach. Then for one day after this operation, these dogs were kept without further insulin and other hormone injections. On the next day, hypophyses of other dogs were transplanted individually into the hypoderm of the heads of these dogs. As controls, ten other dogs were used. Then total pancreatectomy was performed. These dogs were kept under nontreatment for eight days. In all these dogs, blood was sampled through the polyethylene catheter inserted into the femoral vein in the fasting state early every morning for eight days. The blood samples were assayed for blood sugar by the glucose oxidase method, immunoreactive insulin (IRI) by the double antibody method, and immunoreactive glucagon (IRG) by the talc method : glucagon immunoreactivity (GI), by using antibody "K30" highly specific for pancreatic glucagon (Unger, Texas), and total glucagon-like immunoreactivity (total GLI) by using a nonspecific glucagon antibody "K4023" (Novo, Denmark). This difference between total GLI and GI was considered to be Gut GLI. <BR>1) In the control experiment of only total pancreatectomy, blood sugar levels showed significant increases (P<0.001) from 107±7 mg/dl, the value before the operation, to 306±24 mg/dl on the day after the operation; thereafter, they increased gradually, rising to a maximum of 756±124 mg/dl on the eighth day. IRI differed less than 5 μU/ml (P<0.05~0.01) in all the days after pancreatectomy from 14±2 μU/ml, the value before the operation. GI rose significantly (P<0.001) from 70±6 pg/ml, the value before the operation, to 251±32 pg/ml on the second day after the operation and thereafter showed a gradual increase, rising to a maximum of 680±167 pg/ml on the eighth day. Gut GLI increased significantly from 175±7 pg/ml, the value before the operation, to 452±74 pg/ml (P<0.01) on the second day after the operation and to 648±50 pg/ml (P<0.001) on the third day; thereafter, it remained stable at about 650 pg/ml until the eighth day. (Fig. 1) <BR>2) In the hypophysectomized dogs after total pancreatectomy, blood sugar levels decreased significantly (P<0.05) from 362±22 mg/dl, the value before hypophysectomy, to 278±24 mg/dl on the day after hypophysectomy, and to 255±21 mg/dl, still lower on the second day. GI showed a significant decrease (P<0.05) from 438±36 pg/ml, the value before hypophysectomy, to 305±46 pg/ml on the day after the operation and to 262±52 pg/ml on the second day. However, Gut GLI showed no significant changes after hypophysectomy. (Fig. 2) <BR>3) In the dogs which received hypophysis-transplantation after hypophysectomy following total pancreatectomy, blood sugar levels increased significantly (P<0.05) from 255±21 mg/dl, the value before transplantation. to 359±35 mg/dl on the second day after transplantation.
- 一般社団法人 日本内分泌学会の論文
著者
関連論文
- カフェインの心拍数並びに不整脈に及ぼす効果 : 日本循環器学会第72回近畿地方会
- 肝膿瘍, 細菌性腹膜炎, 膿胸の発症機序として bacterial translocation の関与が考えられた糖尿病患者の1例
- イヌにおける選択的β3アドレナリン作動薬の抗肥満効果 : (II)イヌβ3アドレナリン作動薬の慢性投与による褐色脂肪細胞の増加と体脂肪の減少
- イヌにおける選択的β3アドレナリン作動薬の抗肥満効果 : (I)イヌβ3アドレナリン受容体の発現とその作動薬によるin vivoでの脂肪動員
- 糖尿病教育ワークショップが糖尿病医療スタッフの意識や態度に与える影響について
- β_3-AR遺伝子多型における減量後の追跡調査
- 食事・運動療法とβ_3-AR遺伝子多型における食行動の認知的変容
- 両掌間誘導BI(bioelectrical impedance)法による体脂肪測定器の開発
- マウスにおいてβ3-アドレナリン作動薬は骨格筋の脱共役蛋白質発現を誘導する
- 地域における糖尿病対策の新たな展開 - プリシード・プロシードモデルの応用 -
- 両掌間誘導BI法体脂肪計の健診スクリーニング指標としての有用性検討
- S-4 耐糖能異常合併肥満症患者に対する防風通聖散のインスリン抵抗性改善効果
- グループワークやロールプレイを用いた糖尿病教室-患者のやる気・問題解決能力を引き出す技法-
- 肥満女性の体力とβ_3-アドレナリン受容体遺伝子多型の関係
- 5.肥満関連遺伝子情報が健康体力水準に及ぼす影響(第122回日本体力医学会関東地方会)
- Acanthosis nigricansと著明な高インスリン血症を呈した肥満の1例 -高脂肪食摂取とβ_3アドレナリン受容体ミスセンス変異の関与-
- 肥満型糖尿病女性患者に対するストレスマネージメント併用療法の意義
- 防風通聖散の抗肥満作用機序解明に関する基礎的研究 : MSG肥満マウスの褐色脂肪組織活性化作用について
- β_3受容体作働薬CL316,243の存在部位別にみたラット白色脂肪細胞の脂肪分解能
- 抗肥満作用を有するβ3アドレナリン受容体の脂肪組織でのUp-regulation : 動物
- カテコールアミン受容体とインスリン抵抗性
- 肥満における遺伝子多型の臨床的意義
- 管理栄養士に知ってほしい日本人肥満者の特徴と病態及び治療法
- 肥満を伴う2型糖尿病患者における軽度レジスタンス運動のインスリン抵抗性改善効果について
- 胃腸切除犬における血中グルカゴン動態:-健常時における膵特異性グルカゴン抗体反応性腸管グルカゴンの存在と膵外グルカゴンの血糖維持作用について-
- SomatostatinのInsulinおよびGlucagon分泌抑制作用に関する実験的研究:-Somatostatin投与時の末梢血IRI及びIRGの変化について-
- 我糖尿病外来における13年間の観察
- 糖尿病性昏睡と甲状腺クリーゼの合併例
- 糖尿病患者の血糖, IRI, GH及びNEFAに及ぼすMaltose静脈内持続投与の影響
- 静脈内ブドウ糖持続負荷試験について
- 交感神経活動の調節機構解明に関する研究:視床下部性肥満マウスを用いての検討
- 腸管グルカゴンに及ぼす下垂体の影響